(Reuters) - "The flash card is misleading because it presents
unsubstantiated superiority claims and overstates the efficacy
of Abelcet," the Food and Drug Administration said in a letter
to the company posted on the agency Web site.
Abelcet is an injectable form of the anti-fungal drug
amphotericin B. It is approved the treatment of invasive fungal
infections in patients who do not respond to or cannot tolerate
conventional amphotericin B.
Read more at Reuters.com Government Filings News
unsubstantiated superiority claims and overstates the efficacy
of Abelcet," the Food and Drug Administration said in a letter
to the company posted on the agency Web site.
Abelcet is an injectable form of the anti-fungal drug
amphotericin B. It is approved the treatment of invasive fungal
infections in patients who do not respond to or cannot tolerate
conventional amphotericin B.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment